Patient Leaflet Updated 04-Sep-2024 | Flynn Pharma Ltd
Cefaclor Flynn 375 mg Prolonged-Release Tablets
Cefaclor Flynn 375 mg Prolonged-Release Tablets
cefaclor
1. What Cefaclor Flynn prolonged-release tablets are and what they are used for
2. What you need to know before you take Cefaclor Flynn prolonged-release tablets
3. How to take Cefaclor Flynn prolonged-release tablets
4. Possible side effects
5. How to store Cefaclor Flynn prolonged-release tablets
6. Contents of the pack and other information
Cefaclor Flynn prolonged-release tablets are long-acting tablets. They contain the active ingredient cefaclor, which is an antibiotic.
Cefaclor Flynn prolonged-release tablets are used to treat the following infections caused by bacteria that can be killed by cefaclor:
Talk to your doctor or pharmacist before taking Cefaclor Flynn prolonged-release tablets
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription. This is especially important of the following, as they may interact with your Cefaclor Flynn prolonged-release tablets:
It may still be all right for you to be given Cefaclor Flynn prolonged-release tablets and your doctor will be able to decide what is suitable for you.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Cefaclor Flynn prolonged-release tablets should not affect your ability to drive or use machines.
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
The tablets should not be cut, crushed or chewed.
Adults and the elderly
For pharyngitis, bronchitis, tonsillitis, lower urinary tract infections, and skin infections, the usual dose is 375 mg (one tablet) taken orally twice daily.
For pneumonia, the usual dose is 750 mg (two tablets) taken orally twice daily.
Patients with a severe kidney disorder or patients receiving dialysis may need a different dose.
Cefaclor Flynn prolonged-release tablets are not recommended for children.
Go to the nearest accident and emergency department or tell your doctor straight away.
If you miss a dose, take one as soon as you can. If you have missed several doses, tell your doctor. Do not take a double dose to make up for a forgotten dose.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, Cefaclor Flynn prolonged-release tablets can cause side effects, although not everybody gets them. All medicines can cause allergic reactions, although serious allergic reactions are very rare.
Tell your doctor immediately if you get any sudden wheeziness, difficulty in breathing, swelling of the eyelids, face or lips, rash or itching (especially affecting your whole body).
The following side effects are serious. You should stop taking this medicine and tell your doctor immediately if you experience them:
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not store above 25 °C. Store in the original package in order to protect from light.
Do not use this medicine after the expiry date which is stated on the carton. The expiry date refers to the last day of that month.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
The active substance is cefaclor.
The other ingredients are:
mannitol, methylhydroxypropylcellulose, hydroxypropylcellulose, methacrylic acid copolymer, stearic acid, magnesium stearate, titanium dioxide (E171), polyethylene glycol, propylene glycol, indigo carmine aluminium lake (E132) and talc.
Cefaclor Flynn prolonged-release tablets are blue, capsule-shaped film-coated tablets, marked GP5.
Cefaclor Flynn prolonged-release tablets are supplied in blister packs of 2 or 14.
Not all pack sizes may be marketed.
This leaflet was last revised in March 2024
Hertlands House, Primett Road, Stevenage, Hertfordshire, SG1 3EE, UK
+44 (0)1438 727822
+44 (0)1438 727822
http://www.flynnpharma.com